Novel Pharmacological Approach to the Treatment of Alzheimer’s Disease

Alzheimer's disorder is one of the maximum devastating mind problems of aged humans It is an undertreated and under-identified disorder this is turning into a chief public health problem. The remaining decade has witnessed a progressively growing attempt directed at discovering the etiology of the disease and developing pharmacological treatment An overview of Alzheimer's as a disease state and its pharmacological and non-pharmacological management is provided in the paper. Caring for the person diagnosed with Alzheimer's may be taxing and thus caring for the carer is also described. Currently to be had remedies i.e. Acetylcholinesterase inhibitors (rivastigmine, galantamine, donepezil) and N-methyl d-aspartate receptor antagonist (memantine) contribute minimal impact on the disease and target late aspects of the disease. These tablets slow down the development of the disease, offer symptomatic relief but fail to achieve a definite cure.